{
  "DOI": "10.1038/s41431-021-00922-w",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-021-00922-w",
  "alternative-id": [
    "922"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "27 January 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "19 April 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "2 June 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "24 June 2021"
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "The authors declare no competing interests."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0002-6650-9702",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Turbitt",
      "given": "Erin",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "D’Amanda",
      "given": "Celeste",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Hyman",
      "given": "Sarah",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Weber",
      "given": "Jayne Dixon",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Bridges",
      "given": "John F. P.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-3053-7453",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Peay",
      "given": "Holly L.",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0001-9665-8963",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Biesecker",
      "given": "Barbara B.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2021,
        6,
        24
      ]
    ],
    "date-time": "2021-06-24T02:02:39Z",
    "timestamp": 1624500159000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        1,
        1
      ]
    ],
    "date-time": "2023-01-01T09:44:25Z",
    "timestamp": 1672566265000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        5,
        1
      ]
    ],
    "date-time": "2023-05-01T22:52:43Z",
    "timestamp": 1682981563921
  },
  "is-referenced-by-count": 4,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "8",
  "issued": {
    "date-parts": [
      [
        2021,
        6,
        24
      ]
    ]
  },
  "journal-issue": {
    "issue": "8",
    "published-print": {
      "date-parts": [
        [
          2021,
          8
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            6,
            24
          ]
        ],
        "date-time": "2021-06-24T00:00:00Z",
        "timestamp": 1624492800000
      }
    },
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            6,
            24
          ]
        ],
        "date-time": "2021-06-24T00:00:00Z",
        "timestamp": 1624492800000
      }
    }
  ],
  "link": [
    {
      "URL": "https://www.nature.com/articles/s41431-021-00922-w.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-021-00922-w",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-021-00922-w.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1245-1251",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2021,
        6,
        24
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2021,
        6,
        24
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2021,
        8
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1038/s12276-018-0129-7",
      "author": "DC Tărlungeanu",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Exp Mol Med",
      "key": "922_CR1",
      "unstructured": "Tărlungeanu DC, Novarino G. Genomics in neurodevelopmental disorders: an avenue to personalized medicine. Exp Mol Med. 2018;50:1–7.",
      "volume": "50",
      "year": "2018"
    },
    {
      "DOI": "10.1097/DBP.0b013e318236c0e1",
      "author": "DB Bailey",
      "doi-asserted-by": "publisher",
      "first-page": "62",
      "journal-title": "J Dev Behav Pediatr",
      "key": "922_CR2",
      "unstructured": "Bailey DB, Raspa M, Bishop E, Olmsted M, Mallya UG, Berry-Kravis E. Medication utilization for targeted symptoms in children and adults with fragile X syndrome: US survey. J Dev Behav Pediatr. 2012;33:62–9.",
      "volume": "33",
      "year": "2012"
    },
    {
      "key": "922_CR3",
      "unstructured": "U.S. Food and Drug Administration. Learn about FDA patient engagement. U.S. Food and Drug Administration; 2020. https://www.fda.gov/patients/learn-about-fda-patient-engagement."
    },
    {
      "DOI": "10.1038/nrd.2017.221",
      "author": "EM Berry-Kravis",
      "doi-asserted-by": "publisher",
      "first-page": "280",
      "journal-title": "Nat Rev Drug Discov",
      "key": "922_CR4",
      "unstructured": "Berry-Kravis EM, Lindemann L, Jønch AE, Apostol G, Bear MF, Carpenter RL, et al. Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome. Nat Rev Drug Discov. 2018;17:280–99.",
      "volume": "17",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.chc.2007.03.001",
      "author": "AL Reiss",
      "doi-asserted-by": "publisher",
      "first-page": "663",
      "journal-title": "Child Adolesc Psychiatr Clin N Am",
      "key": "922_CR5",
      "unstructured": "Reiss AL, Hall SS. Fragile X syndrome: assessment and treatment implications. Child Adolesc Psychiatr Clin N Am. 2007;16:663–75.",
      "volume": "16",
      "year": "2007"
    },
    {
      "DOI": "10.1352/0895-8017(2008)113[44:CSAABI]2.0.CO;2",
      "author": "SS Hall",
      "doi-asserted-by": "publisher",
      "first-page": "44",
      "journal-title": "Am J Ment Retard",
      "key": "922_CR6",
      "unstructured": "Hall SS, Lightbody AA, Reiss AL. Compulsive, self-injurious, and autistic behavior in children and adolescents with fragile X syndrome. Am J Ment Retard. 2008;113:44–53.",
      "volume": "113",
      "year": "2008"
    },
    {
      "DOI": "10.1542/peds.2008-0317",
      "author": "RJ Hagerman",
      "doi-asserted-by": "publisher",
      "first-page": "378",
      "journal-title": "Pediatrics.",
      "key": "922_CR7",
      "unstructured": "Hagerman RJ, Berry-Kravis E, Kaufmann WE, Ono MY, Tartaglia N, Lachiewicz A, et al. Advances in the treatment of fragile X syndrome. Pediatrics. 2009;123:378–90.",
      "volume": "123",
      "year": "2009"
    },
    {
      "key": "922_CR8",
      "unstructured": "U.S. National Library of Medicine. ClinicalTrials.gov. U.S. National Library of Medicine; 2020. https://clinicaltrials.gov/."
    },
    {
      "DOI": "10.1136/jme.2010.040220",
      "author": "HR Fisher",
      "doi-asserted-by": "publisher",
      "first-page": "544",
      "journal-title": "J Med Ethics",
      "key": "922_CR9",
      "unstructured": "Fisher HR, McKevitt C, Boaz A. Why do parents enrol their children in research: a narrative synthesis. J Med Ethics. 2011;37:544–51.",
      "volume": "37",
      "year": "2011"
    },
    {
      "DOI": "10.1177/1740774511414444",
      "author": "TH Truong",
      "doi-asserted-by": "publisher",
      "first-page": "616",
      "journal-title": "Clin Trials",
      "key": "922_CR10",
      "unstructured": "Truong TH, Weeks JC, Cook EF, Joffe S. Altruism among participants in cancer clinical trials. Clin Trials. 2011;8:616–23.",
      "volume": "8",
      "year": "2011"
    },
    {
      "DOI": "10.1186/1472-6939-12-1",
      "author": "MC de Vries",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "BMC Med Ethics",
      "key": "922_CR11",
      "unstructured": "de Vries MC, Houtlosser M, Wit JM, Engberts DP, Bresters D, Kaspers GJ, et al. Ethical issues at the interface of clinical care and research practice in pediatric oncology: a narrative review of parents’ and physicians’ experiences. BMC Med Ethics. 2011;12:1–11.",
      "volume": "12",
      "year": "2011"
    },
    {
      "DOI": "10.1016/S0140-6736(00)03401-2",
      "author": "SA Mason",
      "doi-asserted-by": "publisher",
      "first-page": "2045",
      "journal-title": "Lancet",
      "key": "922_CR12",
      "unstructured": "Mason SA, Allmark PJ, Group ES. Obtaining informed consent to neonatal randomised controlled trials: interviews with parents and clinicians in the Euricon study. Lancet. 2000;356:2045–51.",
      "volume": "356",
      "year": "2000"
    },
    {
      "DOI": "10.7812/TPP/16-009",
      "author": "TA Becerra",
      "doi-asserted-by": "crossref",
      "first-page": "16",
      "journal-title": "Perm J",
      "key": "922_CR13",
      "unstructured": "Becerra TA, Massolo ML, Yau VM, Owen-Smith AA, Lynch FL, Crawford PM, et al. A survey of parents with children on the autism spectrum: experience with services and treatments. Perm J. 2017;21:16–009.",
      "volume": "21",
      "year": "2017"
    },
    {
      "DOI": "10.1002/eahr.500014",
      "author": "E Paquette",
      "doi-asserted-by": "publisher",
      "first-page": "2",
      "journal-title": "J Ethics Hum Res",
      "key": "922_CR14",
      "unstructured": "Paquette E, Shukla A, Davidson J, Rychlik K, Davis M. Burden or opportunity? Parent experiences when approached for research in a pediatric intensive care unit. J Ethics Hum Res. 2019;41:2–12.",
      "volume": "41",
      "year": "2019"
    },
    {
      "DOI": "10.1007/s40271-017-0250-z",
      "author": "FR Johnson",
      "doi-asserted-by": "publisher",
      "first-page": "523",
      "journal-title": "Patient",
      "key": "922_CR15",
      "unstructured": "Johnson FR, Beusterien K, Özdemir S, Wilson L. Giving patients a meaningful voice in United States regulatory decision making: the role for health preference research. Patient. 2017;10:523–6.",
      "volume": "10",
      "year": "2017"
    },
    {
      "DOI": "10.1007/s10897-017-0190-8",
      "author": "RR Moultrie",
      "doi-asserted-by": "publisher",
      "first-page": "416",
      "journal-title": "J Genet Couns",
      "key": "922_CR16",
      "unstructured": "Moultrie RR, Lewis MA, Paquin RS, Lucas A, Jarecki J, Peay HL. An evidence-based, community-engaged approach to develop an interactive deliberation tool for pediatric neuromuscular trials. J Genet Couns. 2018;27:416–25.",
      "volume": "27",
      "year": "2018"
    },
    {
      "DOI": "10.1111/jir.12605",
      "author": "C D’Amanda",
      "doi-asserted-by": "publisher",
      "first-page": "926",
      "journal-title": "J Intellect Disabil Res",
      "key": "922_CR17",
      "unstructured": "D’Amanda C, Peay H, Wheeler A, Turbitt E, Biesecker BB. Fragile X syndrome clinical trials: exploring parental decision making. J Intellect Disabil Res. 2019;63:926–35.",
      "volume": "63",
      "year": "2019"
    },
    {
      "DOI": "10.1177/1740774513512726",
      "author": "H Peay",
      "doi-asserted-by": "publisher",
      "first-page": "77",
      "journal-title": "Clin Trials",
      "key": "922_CR18",
      "unstructured": "Peay H, Tibben A, Fisher T, Brenna E, Biesecker B. Expectations and experiences of investigators and parents involved in a clinical trial for Duchenne/Becker muscular dystrophy. Clin Trials. 2013;11:77–85.",
      "volume": "11",
      "year": "2013"
    },
    {
      "DOI": "10.1016/B978-0-12-804461-2.00022-6",
      "doi-asserted-by": "crossref",
      "key": "922_CR19",
      "unstructured": "Richstein J, Cohen J, Hardiman B. Fragile X research from a parental perspective. In: Fragile X syndrome. Elsevier; 2017. p. 457–70."
    },
    {
      "DOI": "10.1038/gim.0b013e3182310ba0",
      "author": "DC Landy",
      "doi-asserted-by": "publisher",
      "first-page": "223",
      "journal-title": "Genet Med",
      "key": "922_CR20",
      "unstructured": "Landy DC, Brinich MA, Colten ME, Horn EJ, Terry SF, Sharp RR. How disease advocacy organizations participate in clinical research: a survey of genetic organizations. Genet Med. 2012;14:223–8.",
      "volume": "14",
      "year": "2012"
    },
    {
      "DOI": "10.1002/eahr.500064",
      "author": "MA Cascio",
      "doi-asserted-by": "publisher",
      "first-page": "2",
      "journal-title": "Ethics Hum Res.",
      "key": "922_CR21",
      "unstructured": "Cascio MA, Weiss JA, Racine E. Person-oriented research ethics to address the needs of participants on the autism spectrum. Ethics Hum Res. 2020;42:2–16.",
      "volume": "42",
      "year": "2020"
    },
    {
      "DOI": "10.1111/jocn.15173",
      "author": "G Özalp Gerçeker",
      "doi-asserted-by": "publisher",
      "first-page": "1151",
      "journal-title": "J Clin Nurs",
      "key": "922_CR22",
      "unstructured": "Özalp Gerçeker G, Ayar D, Özdemir EZ, Bektaş M. Effects of virtual reality on pain, fear and anxiety during blood draw in children aged 5–12 years old: a randomised controlled study. J Clin Nurs. 2020;29:1151–61.",
      "volume": "29",
      "year": "2020"
    },
    {
      "DOI": "10.1177/1049732315616622",
      "author": "DB Nicholas",
      "doi-asserted-by": "publisher",
      "first-page": "921",
      "journal-title": "Qual Health Res",
      "key": "922_CR23",
      "unstructured": "Nicholas DB, Zwaigenbaum L, Ing S, MacCulloch R, Roberts W, McKeever P, et al. “Live it to understand it” the experiences of mothers of children with autism spectrum disorder. Qual Health Res. 2016;26:921–34.",
      "volume": "26",
      "year": "2016"
    },
    {
      "DOI": "10.1038/s41576-020-0260-x",
      "author": "Y Bombard",
      "doi-asserted-by": "publisher",
      "first-page": "505",
      "journal-title": "Nat Rev Genet",
      "key": "922_CR24",
      "unstructured": "Bombard Y, Hayeems RZ. How digital tools can advance quality and equity in genomic medicine. Nat Rev Genet. 2020;21:505–6.",
      "volume": "21",
      "year": "2020"
    },
    {
      "DOI": "10.1002/14651858.CD009736.pub2",
      "doi-asserted-by": "publisher",
      "key": "922_CR25",
      "unstructured": "Gillies K, Cotton SC, Brehaut JC, Politi MC, Skea Z. Decision aids for people considering taking part in clinical trials. Cochrane Database Syst Rev. 2015. https://doi.org/10.1002/14651858.CD009736.pub2."
    },
    {
      "DOI": "10.1007/s40273-016-0429-5",
      "author": "KL Cheung",
      "doi-asserted-by": "publisher",
      "first-page": "1195",
      "journal-title": "Pharmacoeconomics.",
      "key": "922_CR26",
      "unstructured": "Cheung KL, Wijnen BF, Hollin IL, Janssen EM, Bridges JF, Evers SM, et al. Using best–worst scaling to investigate preferences in health care. Pharmacoeconomics. 2016;34:1195–209.",
      "volume": "34",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.ijresmar.2012.10.002",
      "author": "J Louviere",
      "doi-asserted-by": "publisher",
      "first-page": "292",
      "journal-title": "Int J Res Mark",
      "key": "922_CR27",
      "unstructured": "Louviere J, Lings I, Islam T, Gudergan S, Flynn T. An introduction to the application of (case 1) best–worst scaling in marketing research. Int J Res Mark. 2013;30:292–303.",
      "volume": "30",
      "year": "2013"
    },
    {
      "DOI": "10.2165/11539660-000000000-00000",
      "author": "J Louviere",
      "doi-asserted-by": "publisher",
      "first-page": "275",
      "journal-title": "Patient",
      "key": "922_CR28",
      "unstructured": "Louviere J, Flynn TN. Using best-worst scaling choice experiments to measure public perceptions and preferences for healthcare reform in Australia. Patient. 2010;3:275–83.",
      "volume": "3",
      "year": "2010"
    },
    {
      "DOI": "10.2147/PPA.S151752",
      "author": "JF Bridges",
      "doi-asserted-by": "publisher",
      "first-page": "647",
      "journal-title": "Patient Prefer Adherence",
      "key": "922_CR29",
      "unstructured": "Bridges JF, Oakes AH, Reinhart CA, Voyard E, O’Donoghue B. Developing and piloting an instrument to prioritize the worries of patients with acute myeloid leukemia. Patient Prefer Adherence. 2018;12:647–55.",
      "volume": "12",
      "year": "2018"
    },
    {
      "DOI": "10.1007/s00431-016-2715-9",
      "author": "K Tromp",
      "doi-asserted-by": "publisher",
      "first-page": "599",
      "journal-title": "Eur J Pediatr",
      "key": "922_CR30",
      "unstructured": "Tromp K, Zwaan CM, van de Vathorst S. Motivations of children and their parents to participate in drug research: a systematic review. Eur J Pediatr. 2016;175:599–612.",
      "volume": "175",
      "year": "2016"
    },
    {
      "DOI": "10.1002/hec.1369",
      "author": "M Ryan",
      "doi-asserted-by": "publisher",
      "first-page": "321",
      "journal-title": "Health Econ",
      "key": "922_CR31",
      "unstructured": "Ryan M, Watson V, Entwistle V. Rationalising the ‘irrational’: a think aloud study of discrete choice experiment responses. Health Econ. 2009;18:321–36.",
      "volume": "18",
      "year": "2009"
    },
    {
      "DOI": "10.1017/CBO9781107337855",
      "doi-asserted-by": "crossref",
      "key": "922_CR32",
      "unstructured": "Louviere JJ, Flynn TN, Marley AAJ. Best-worst scaling: theory, methods and applications. Cambridge University Press, Cambridge; 2015."
    },
    {
      "author": "TN Flynn",
      "first-page": "259",
      "journal-title": "Expert Rev Pharm Outcomes Res.",
      "key": "922_CR33",
      "unstructured": "Flynn TN. Valuing citizen and patient preferences in health: recent developments in three types of best–worst scaling. Expert Rev Pharm Outcomes Res. 2014;10:259–67.",
      "volume": "10",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.socscimed.2010.03.008",
      "author": "TN Flynn",
      "doi-asserted-by": "publisher",
      "first-page": "1957",
      "journal-title": "Soc Sci Med",
      "key": "922_CR34",
      "unstructured": "Flynn TN, Louviere JJ, Peters TJ, Coast J. Using discrete choice experiments to understand preferences for quality of life. Variance-scale heterogeneity matters. Soc Sci Med. 2010;70:1957–65.",
      "volume": "70",
      "year": "2010"
    },
    {
      "key": "922_CR35",
      "unstructured": "McFadden D. Conditional logit analysis of qualitative choice behavior. In: Frontiers in econometrics. Academic Press; 1973. p. 105–42."
    },
    {
      "DOI": "10.1097/00000542-200310000-00012",
      "author": "AR Tait",
      "doi-asserted-by": "publisher",
      "first-page": "819",
      "journal-title": "J Am Soc Anesthesiol",
      "key": "922_CR36",
      "unstructured": "Tait AR, Voepel-Lewis T, Malviya S. Participation of children in clinical research factors that influence a parent’s decision to consent. J Am Soc Anesthesiol. 2003;99:819–25.",
      "volume": "99",
      "year": "2003"
    },
    {
      "DOI": "10.1067/mpd.2003.192",
      "author": "PH Caldwell",
      "doi-asserted-by": "publisher",
      "first-page": "554",
      "journal-title": "J Pediatr",
      "key": "922_CR37",
      "unstructured": "Caldwell PH, Butow PN, Craig JC. Parents’ attitudes to children’s participation in randomized controlled trials. J Pediatr. 2003;142:554–9.",
      "volume": "142",
      "year": "2003"
    }
  ],
  "reference-count": 37,
  "references-count": 37,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-021-00922-w"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Parent clinical trial priorities for fragile X syndrome: a best–worst scaling"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "29"
}